Fei Chen, PhD, Professor, Wayne State University
Cancer stem cells have been recently recognized as the sources of driving long-term growth, therapeutic resistance, metastasis, and recurrence of the tumors. However, many key questions on the origin, stemness, energy metabolism, epigenetic reprogramming, lineage differentiation, etc, of the cancer stem cells remain elusive, which hamper the development of efficient therapeutic targeting of these cells to eradicate cancers.
Accordingly, this special issue, by targeting the cancer stem cells, will emphasize our most recent understandings on the characteristics and the progression in developing drugs targeting the cancer stem cells. The following topics but not limited to are strongly encouraged:
Both review and research articles will be considered. For more information on the journal and its style, please refer to “Instructions for Authors” at http://thno.org/ms/author. All the invited and contributed manuscripts will be pre-screened by the guest editors followed by the standard peer-review procedure, usually two to four experts in the field, of the Journal “Theranostics”. The deadline for Proposal is set for June 30, 2019, and the full manuscript submission DEADLINE is set for October 30, 2019. The first decision will be made within 4 weeks from submission after peer-review process.
Manuscripts for this special issue should be submitted online at http://www.thno.org/ms/submit (mark “Special Issue on Targeting Cancer Stem Cells" in the "Suggested reviewers” field to identify the manuscript).
All inquiries should be sent to the guest editor(s) at the above email address.